SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Form 8.3 - Warpaint London plc

6 Dec 2024 15:01

Premier Miton Group Plc - Form 8.3 - Warpaint London plc

Premier Miton Group Plc - Form 8.3 - Warpaint London plc

PR Newswire

LONDON, United Kingdom, December 06

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

PREMIER MITON GROUP PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Warpaint London plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

05/12/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state "N/A"

No

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ords

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,075,098

1.38%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

1,075,098

1.38%

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

25p ordinary

Details, including nature of the rights concerned and relevant percentages:

Agreed to subscribe to 222,884 new shares at a price of 510p per share GPB in the Warpaint London plc placing announced on 5 Dec 2024.

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

25p ordinary

purchase

94,937

538

 

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

n/a

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

n/a

 

 

 

 

 

 

 

 

(ii) Exercise

 

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

n/a

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

n/a

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

06/12/2024

Contact name:

Helena Celica

Telephone number:

01483 400428

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.



Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM and Posting of Annual Report
29th Apr 20267:00 amRNSResults for the year ended 31 December 2025
20th Apr 20267:00 amRNSNotice of Results
9th Apr 20269:41 amRNSBlock Listing Return
17th Feb 20261:34 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSRule 19.6(c) confirmation re Brand Architekts
9th Feb 20262:21 pmRNSCompletion of the acquisition of the Barry M brand
9th Feb 20267:00 amRNSAcquisition of Barry M brand & FY25 Trading Update
24th Nov 202512:16 pmRNSHolding(s) in Company
10th Nov 20252:06 pmRNSBLOCK LISTING RETURN
29th Oct 20252:52 pmRNSHolding(s) in Company
9th Oct 20251:36 pmRNSBlock listing Return
8th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
17th Sep 20259:12 amRNSHolding(s) in Company
10th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSNotice of Results
21st Aug 20252:23 pmRNSHolding(s) in Company
19th Aug 20258:21 amRNSHolding(s) in Company
17th Jun 202510:46 amRNSResult of AGM
17th Jun 20257:00 amRNSAGM Statement
28th May 20252:43 pmRNSHolding(s) in Company
20th May 202512:01 pmRNSHolding(s) in Company
20th May 20257:30 amRNSNotice of AGM and Posting of Annual Report
13th May 20254:54 pmRNSBlock listing Interim Return
29th Apr 20257:00 amRNSResults for the year ended 31 December 2024
14th Apr 20257:00 amRNSNotice of Results
9th Apr 20253:07 pmRNSBLOCK LISTING RETURN
24th Mar 20251:38 pmRNSAnnouncement pursuant to AIM rule 13
13th Feb 20253:18 pmGNWForm 8.3 - Warpaint London Plc
13th Feb 20251:52 pmRNSForm 8.3 - Warpaint London plc
13th Feb 202512:17 pmRNSForm 8.3 - Warpaint London Plc
13th Feb 202511:50 amRNSForm 8.5 (EPT/RI)
13th Feb 202511:24 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
12th Feb 20255:56 pmRNSForm 8.3 - Warpaint London plc Amend
12th Feb 20253:46 pmRNSDirector/PDMR Dealing
12th Feb 20253:37 pmRNSApplication for Admission of Shares and TVR
12th Feb 20253:25 pmRNSReplacement: Scheme Effective
12th Feb 20253:10 pmRNSForm 8.3 - Warpaint London plc
12th Feb 20252:41 pmGNWForm 8.3 - Warpaint London Plc
12th Feb 20252:19 pmRNSForm 8.3 - Warpaint London Plc
12th Feb 202512:05 pmPRNForm 8.3 - Warpaint London Plc
12th Feb 202511:48 amRNSForm 8.3 - Warpaint London plc
12th Feb 202511:35 amRNSForm 8.3 - Warpaint London PLC
12th Feb 202510:59 amRNSForm 8.5 (EPT/RI)
12th Feb 202510:54 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 20253:04 pmGNWForm 8.3 - Warpaint London Plc
11th Feb 202512:19 pmRNSForm 8.3 - Warpaint London plc
11th Feb 202511:03 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 202510:49 amRNSForm 8.5 (EPT/RI)
11th Feb 202510:36 amRNSForm 8.3 - Warpaint London plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.